# EMPAGLIFLOZIN AND LINAGLIPTIN
> **ANDA212359** · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABS PVT LTD · Approved 2020-07-07
## Drug
- **FDA Application Number:** ANDA212359
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMPAGLIFLOZIN AND LINAGLIPTIN
- **Generic name:** Empagliflozin
- **Active ingredients:** EMPAGLIFLOZIN; LINAGLIPTIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN LABS PVT LTD
- **First approval:** 2020-07-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212359)
---
*AI Analytics · CC0 1.0*